Edwards Lifesciences Aktie
WKN: 936853 / ISIN: US28176E1082
|
23.04.2026 22:42:32
|
Edwards Lifesciences Corp. Q1 Income Rises
(RTTNews) - Edwards Lifesciences Corp. (EW) released a profit for its first quarter that Increases, from the same period last year
The company's earnings came in at $380.7 million, or $0.66 per share. This compares with $363.6 million, or $0.62 per share, last year.
Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $455.2 million or $0.78 per share for the period.
The company's revenue for the period rose 16.7% to $1.648 billion from $1.412 billion last year.
Edwards Lifesciences Corp. earnings at a glance (GAAP) :
-Earnings: $380.7 Mln. vs. $363.6 Mln. last year. -EPS: $0.66 vs. $0.62 last year. -Revenue: $1.648 Bln vs. $1.412 Bln last year.
-Guidance: Next quarter EPS guidance: $ 0.70 To $ 0.76 Next quarter revenue guidance: $ 1.66 B To $ 1.74 B Full year EPS guidance: $ 2.95 To $ 3.05 Full year revenue guidance: $ 6.5 B To $ 6.9 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.
Analysen zu Edwards Lifesciences Corp.
Aktien in diesem Artikel
| Edwards Lifesciences Corp. | 74,84 | -0,43% |
|